In addition to inhibitory effects on the activation of JAK and Src kinase, the study by Kim et al. further demonstrated the inhibitory effect of formononetin on the interleukin-6 activated phosphorylation of STAT3 in multiple myeloma cells. The gene discussed is STAT3; the disease is plasma cell myeloma.